2nd Aug 2021
Windlas Biotech is a key player in the CDMO (contract development & manufacturing organization), is a specialized activity wherein a pharma company offers the niche service of additional manufacturing capacity or even specialized research service
1st Aug 2021
Supriya Lifesciences, a manufacturer of active pharma ingredients (APIs) has filed the draft red herring prospectus (DRHP) with SEBI for its proposed IPO. The company is planning to raise Rs.1,200 crore from the primary market, which will include a f
Aptus value Housing caters to the fast growing low-to-mid end customers with a predominant focus on the self-employed segment. Despite this focus on the volatile self-employed segment, Aptus has managed to keep the gross NPAs under check. Here is a q
Ami Organics has already filed the draft red herring prospectus with SEBI for its proposed public issue of shares. The company is into the fast growing and lucrative specialty chemicals space and has seen rapid growth in the last few years. Also, glo
31st Jul 2021
CarTrade, founded in 2009, is a platform for potential buyers and sellers to register and buy and sell used cars as well as new cars. The founder Vinay Sanghi, is a veteran of the secondary car market, having spent a long time with Mahindra First Cho
Exxaro is into the manufacture and marketing of vitrified tiles, which are extensively used as an alternative to marble flooring in homes and also in offices. They are easier to maintain. Exxaro is into the manufacture of double-charged vitrified til
Devyani International may not be known as a company but its brands are ragingly popular among Indian households, especially among the Indian youth, Devyani is the largest franchisee of Yum Brands in India and operates a massive chain of quick-service
Krsnaa runs a chain of diagnostic centres offering a wide array of diagnostic services including imaging, radiology, routine clinical laboratory tests, pathology analysis and tele radiology services. These services are offered on a B2B model and is o
30th Jul 2021
The Indian economy is gradually picking up as lockdown restrictions are easing across various states in India. Following the trend, the stock market is also performing well. On account of such positive signs, the IPO market is gaining traction. A lot
The Rs.731 crore Rolex Rings IPO, consisting of Rs.56 crore fresh issue and Rs.675 crore OFS, got a phenomenal response on Day-3. As per the combined bid details put out by the BSE, Rolex Rings IPO was subscribed 130.43X overall, with the bulk of the
Metals have been in the limelight for some time now. Most of the metal stocks have either doubled or tripled since January 2021 and that has been triggered by strong demand and pricing power for steel companies and aluminium. This offset the spike in
Windlas Biotech, a company engaged in formulations CDMO business, is tapping the primary market with an IPO. Windlas will raise Rs.402 crore through a mix of fresh issue and offer for sale. The IPO will open on 04 August and close for subscription on
Open Free Demat Account in 5 mins